Orthofix Reports 1Q17 Revenue
Orthofix posted 1Q17 revenue of US $102.7MM, +4.1% from 1Q16. May 09, 2017
Anika Therapeutics Posts 1Q17 Orthobiologic Revenue
Anika Therapeutics posted 1Q17 orthobiologic revenue of US $20.2MM, +3.3% vs. 1Q16. May 09, 2017
Conventus Orthopaedics Raises $20MM
Conventus Orthopaedics completed a US $20MM equity financing. Funds will support commercialization of proximal humerus fracture repair technology and the development of the Conventus Cageâ„¢ intramedullary implant. May 09, 2017
Episurf Medical Granted Additional US Patent
Episurf Medical was granted a U.S. patent covering its surgical drill guide with depth adjustment functionality, part of the Episealer® joint implant system. May 09, 2017
Carmell Therapeutics to Launch Phase III Study of Bone Healing Accelerant
Carmell Therapeutics will launch a Phase III clinical study for Bone Healing Accelerant, its first Plasma-based Bioactive Material product/indication, designed to treat fractures. May 09, 2017
Aesculap Implant Systems Presents Long-term activL Study Data
Studies indicate that, at 5 years, the activ-L® Artificial Disc from Aesculap Implant Systems had a protective effect on the progression of degenerative disc disease at adjacent levels in 91.2% of patients. May 09, 2017
ZipLine Medical Receives India Regulatory Approval for Zip Skin Closure System
ZipLine Medical received regulatory approval of the Zip® Surgical Skin Closure device in India. May 09, 2017
Histogenics Update: Agreement with Japan PMDA on NeoCart Regulatory Path
Histogenics successfully completed consultations with Japan’s PMDA regarding the regulatory path for NeoCart® autologous cell therapy for the treatment of knee cartilage defects. May 08, 2017
Inspired Spine Presents OLLIF Procedure Study Results
Results from a 124-patient study indicate that Inspired Spine’s OLLIF procedure was completed at ~2x the speed of an open TLIF, and reduced blood loss by >80% vs. TLIF. May 08, 2017
Stryker Orthopaedics 2016 Settlement Program Reaches Milestone
Stryker Howmedica Osteonics/Stryker Orthopaedics informed courts that 95% of additional registered eligible patients have enrolled in its Settlement Program relative to revisions of the Rejuvenate Modular-Neck hip stem and/or ABG II Modular-Neck hip stem. May 08, 2017
